Search Results 1561-1570 of 24315 for Periods

  1. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    ... period and stable low dose of steroids for 2 weeks prior to initiating study treatment. Patients with an established diagnosis of diabetes mellitus type I ...

  2. Interferon alfa-2b (injection route) - Side effects & uses - Mayo Clinic

    Abnormal ejaculation · absent, missed, or irregular menstrual periods · bleeding, burning, inflammation, itching, or pain at the injection site · bone deformity ...

  3. Propofol (intravenous route) - Mayo Clinic

    Propofol injection is used to help you relax or sleep before and during surgery or other medical procedures. This medicine is an anesthetic and a sedative.

  4. Valsartan (oral route) - Mayo Clinic

    Valsartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes blood vessels to tighten. Valsartan relaxes the ...

  5. Vitamin A - Mayo Clinic

    It's also called retinol or retinoic acid. Vitamin A has antioxidant properties. Antioxidants are substances that might protect cells against the effects of ...

  6. Breastfeeding and alcohol: Is it OK to drink? - Mayo Clinic

    Over time, drinking too much might cause the body to make less breast milk. Delay pumping or breastfeeding your baby two hours for each alcoholic drink you ...

  7. Cancer Incidence is a yearly average based on a 5-yr period from (2015-2016), Mortality is a yearly average based on a 5-yr period from (2016-2020). *Target ...

  8. Eosinophilia Causes - Mayo Clinic

    For example, these cells play a key role in the symptoms of asthma and allergies, such as hay fever. Other immune system issues can lead to chronic inflammation ...

  9. Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations - Mayo Clinic

    ... period. Moisturizers and emollients are allowed. The participant is willing to forego medical interventional treatment (i.e., pharmacological or ...

  10. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

    For agents that have known adverse events occurring beyond 7 days after administration, this period must be extended beyond the time during which adverse ...